This novel mechanism by which S. Typhimurium exploits the host Lcn2 and MMP-9 synergy to aggravate inflammation and colitis severity is critical, as it calls for the reinterpretation of studies on microbial pathogenesis; other potential pathogens may also employ similar mechanisms. This evidence concerns the gene LCN2 and colitis.